{"protocolSection": {"identificationModule": {"nctId": "NCT04457973", "orgStudyIdInfo": {"id": "HSC-SN-20-0640"}, "secondaryIdInfos": [{"id": "R15NR018050", "type": "NIH", "link": "https://reporter.nih.gov/quickSearch/R15NR018050"}], "organization": {"fullName": "Florida State University", "class": "OTHER"}, "briefTitle": "Home-based Transcranial Direct Current Stimulation for Pain Management in Persons With Alzheimer's Disease and Related Dementias", "officialTitle": "Home-based Transcranial Direct Current Stimulation (tDCS) for Pain Management in Persons With Alzheimer's Disease and Related Dementias"}, "statusModule": {"statusVerifiedDate": "2023-09", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2020-09-04", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2022-10-19", "type": "ACTUAL"}, "completionDateStruct": {"date": "2022-10-19", "type": "ACTUAL"}, "studyFirstSubmitDate": "2020-07-01", "studyFirstSubmitQcDate": "2020-07-01", "studyFirstPostDateStruct": {"date": "2020-07-07", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2023-08-23", "resultsFirstSubmitQcDate": "2023-09-20", "resultsFirstPostDateStruct": {"date": "2023-10-13", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2023-09-20", "lastUpdatePostDateStruct": {"date": "2023-10-13", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Hyochol Ahn, PhD", "investigatorTitle": "Associate Dean for Research & Professor", "investigatorAffiliation": "Florida State University"}, "leadSponsor": {"name": "Florida State University", "class": "OTHER"}, "collaborators": [{"name": "National Institute of Nursing Research (NINR)", "class": "NIH"}]}, "oversightModule": {"isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true, "isUnapprovedDevice": true, "isUsExport": false}, "descriptionModule": {"briefSummary": "The purpose of this project is to evaluate the preliminary effects of home-based M1-SO applied tDCS (that is, tDCS with the anode over the primary motor cortex and the cathode over the contralateral supraorbital area) on clinical pain in persons with early-stage Alzheimer's disease and Related Dementias (ADRD), to evaluate the preliminary effects of home-based M1-SO applied tDCS on pain-related cortical response in persons with early-stage ADRD, and to evaluate the feasibility and acceptability of home-based M1-SO applied tDCS for pain management in persons with early-stage AD."}, "conditionsModule": {"conditions": ["Alzheimer's Disease and Related Dementias"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER"]}}, "enrollmentInfo": {"count": 40, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Active tDCS", "type": "EXPERIMENTAL", "interventionNames": ["Device: Active tDCS"]}, {"label": "Sham tDCS", "type": "PLACEBO_COMPARATOR", "interventionNames": ["Device: Sham tDCS"]}], "interventions": [{"type": "DEVICE", "name": "Active tDCS", "description": "tDCS with a constant current intensity of 2 milliampere (mA) will be applied for 20 minutes per session daily for 5 days via the Soterix 1x1 tDCS mini-CT Stimulator device with headgear and 5x7 cm saline-soaked surface sponge electrodes.", "armGroupLabels": ["Active tDCS"]}, {"type": "DEVICE", "name": "Sham tDCS", "description": "The electrodes will be placed in the same positions as for active stimulation, but the stimulator will only deliver 2 mA current for 30 seconds.", "armGroupLabels": ["Sham tDCS"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Pain as Assessed by the Mobilization-Observation-Behavior-Intensity-Dementia (MOBID-2) Scale", "description": "Mobilization-Observation-Behavior-Intensity-Dementia (MOBID-2) is a 10 question scale, each question rated from 0-10. The total score ranges between 0-100 with a higher number indicating a worse outcome. The change in total score between the baseline (day 1) and the end of intervention (day 5) is reported.", "timeFrame": "baseline (day 1), end of intervention (day 5)"}], "secondaryOutcomes": [{"measure": "Clinical Pain as Assessed by a Numerical Rating Scale (NRS)", "description": "Numeric Rating Scale (NRS) total score ranges from 0 (no pain) to 100 (most intense pain imaginable). The change in total score between the baseline (day 1) and the end of intervention (day 5) is reported.", "timeFrame": "baseline (day 1), end of intervention (day 5)"}, {"measure": "Behavioral and Psychological Symptoms of Dementia (BPSD) as Measured by the Cohen-Mansfield Agitation Inventory (CMAI)", "description": "Cohen-Mansfield Agitation Inventory (CMAI) is a 29 question scale, each question measured from 1-7. Total score ranges from 29-203 with a higher score indicating a worse outcome. The change in total score between the baseline (day 1) and the end of intervention (day 5) is reported.", "timeFrame": "baseline (day 1), end of intervention (day 5)"}, {"measure": "Behavioral and Psychological Symptoms as Assessed by Neuropsychiatric Inventory (NPI)", "description": "Neuropsychiatric Inventory (NPI) total score ranges from 0-144, with a higher score indicating greater symptoms. The change in total score between the baseline (day 1) and the end of intervention (day 5) is reported.", "timeFrame": "baseline (day 1), end of intervention (day 5)"}, {"measure": "Change in Pain Related Cortical Response Using a Continuous Wave, Multichannel Functional Near-infrared Spectroscopy (fNIRS) Imaging System", "description": "Pain-related cortical response will be measured during thermal pain stimulation using a continuous-wave, multichannel fNIRS imaging system (LIGHTNIRS, Shimadzu, Kyoto, Japan) composed of 8 source and 8 detector channels.\n\nfNIRS signals between each source-to-detector pair are analyzed using a general linear model, Y = X\\*Beta + E , to test for statistical differences between the baseline (day 1) and the end of intervention (day 5).\n\nY is the measured fNIRS signal, X is an array encoding the expected/hypothetical response, E is an error term, and Beta is interpreted as the strength/amplitude of the functional activation.\n\nGreater absolute Beta values denote that the change in cortical response between two sessions is greater.\n\nThe calculated Beta values are expressed in arbitrary units.", "timeFrame": "baseline (day 1), end of intervention (day 5)"}, {"measure": "Acceptability as Measured by the tDCs Experience Questionnaire", "description": "The tDCS experience questionnaire contains 10 questions based on a scale from 0-10, 0 being strongly disagree and 10 being strongly agree. Higher scores indicating greater acceptability for 7 questions and lower scores indicating greater acceptability for 3 reversed questions. Total score ranges from 0-100 with a most desirable score of a 70.", "timeFrame": "end of intervention (day 5)"}, {"measure": "Patient Satisfaction as Measured by the Client Satisfaction Questionnaire (CSQ)", "description": "Client Satisfaction Questionnaire (CSQ) consists of 8 questions, each is rated between 1-4. The total score ranges from 8-32 with a higher score indicating a higher satisfaction.", "timeFrame": "end of intervention (day 5)"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* early-stage Alzhimer's disease and related dementias (ADRD)\n* have caregiver-reported chronic pain (average pain in the past 3 months \u2265 3 out of 10),\n* have a caregiver willing to participate in the study who sees the participant at least 10 hours/week\n* can speak and read English\n* have no plans to change medication regimens during the trial\n\nExclusion Criteria:\n\n* history of brain surgery, brain tumor, seizure, stroke, or intracranial metal implantation\n* alcohol/substance abuse\n* severely diminished cognitive function (i.e., MiniMental Status Exam score \u2264 15)\n* hospitalization within the preceding year for neuropsychiatric illness", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "50 Years", "maximumAge": "90 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Hyochol Ahn, RN,PhD,MSN", "affiliation": "The University of Texas Health Science Center, Houston", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "The University of Texas Health Science Center at Houston", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Active tDCS", "description": "Active tDCS: tDCS with a constant current intensity of 2 milliampere (mA) will be applied for 20 minutes per session daily for 5 days via the Soterix 1x1 tDCS mini-CT Stimulator device with headgear and 5x7 cm saline-soaked surface sponge electrodes."}, {"id": "FG001", "title": "Sham tDCS", "description": "Sham tDCS: The electrodes will be placed in the same positions as for active stimulation, but the stimulator will only deliver 2 mA current for 30 seconds out of 20 minutes per session daily for 5 days via the Soterix 1x1 tDCS mini-CT Stimulator device with headgear and 5x7 cm saline-soaked surface sponge electrodes."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "20"}, {"groupId": "FG001", "numSubjects": "20"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "20"}, {"groupId": "FG001", "numSubjects": "20"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Active tDCS", "description": "2mA current is applied for 20 minutes."}, {"id": "BG001", "title": "Sham tDCS", "description": "2mA current is applied for 30 seconds."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "20"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "40"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "74.10", "spread": "6.20"}, {"groupId": "BG001", "value": "71.90", "spread": "8.97"}, {"groupId": "BG002", "value": "73", "spread": "7.83"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "28"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "12"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "19"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "39"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "2"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "19"}, {"groupId": "BG002", "value": "37"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Pain as Assessed by the Mobilization-Observation-Behavior-Intensity-Dementia (MOBID-2) Scale", "description": "Mobilization-Observation-Behavior-Intensity-Dementia (MOBID-2) is a 10 question scale, each question rated from 0-10. The total score ranges between 0-100 with a higher number indicating a worse outcome. The change in total score between the baseline (day 1) and the end of intervention (day 5) is reported.", "populationDescription": "Comparison of pain intensity changes between two groups at 5 days from baseline", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "baseline (day 1), end of intervention (day 5)", "groups": [{"id": "OG000", "title": "Active tDCS", "description": "2mA current is applied for 20 minutes."}, {"id": "OG001", "title": "Sham tDCS", "description": "2mA current is applied for 30 seconds."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "20"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-2.70", "spread": "2.39"}, {"groupId": "OG001", "value": "-.40", "spread": "1.67"}]}]}]}, {"type": "SECONDARY", "title": "Clinical Pain as Assessed by a Numerical Rating Scale (NRS)", "description": "Numeric Rating Scale (NRS) total score ranges from 0 (no pain) to 100 (most intense pain imaginable). The change in total score between the baseline (day 1) and the end of intervention (day 5) is reported.", "populationDescription": "Comparison of pain intensity changes between two groups at 5 days from baseline", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "baseline (day 1), end of intervention (day 5)", "groups": [{"id": "OG000", "title": "Active tDCS", "description": "2mA current is applied for 20 minutes."}, {"id": "OG001", "title": "Sham tDCS", "description": "2mA current is applied for 30 seconds."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "20"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-13.55", "spread": "14.90"}, {"groupId": "OG001", "value": "-3.30", "spread": "14.81"}]}]}]}, {"type": "SECONDARY", "title": "Behavioral and Psychological Symptoms of Dementia (BPSD) as Measured by the Cohen-Mansfield Agitation Inventory (CMAI)", "description": "Cohen-Mansfield Agitation Inventory (CMAI) is a 29 question scale, each question measured from 1-7. Total score ranges from 29-203 with a higher score indicating a worse outcome. The change in total score between the baseline (day 1) and the end of intervention (day 5) is reported.", "populationDescription": "Comparison of CMAI score changes between two groups at 5 days from baseline", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "baseline (day 1), end of intervention (day 5)", "groups": [{"id": "OG000", "title": "Active tDCS", "description": "2mA current is applied for 20 minutes."}, {"id": "OG001", "title": "Sham tDCS", "description": "2mA current is applied for 30 seconds."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "20"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-2.35", "spread": "5.99"}, {"groupId": "OG001", "value": "-2.95", "spread": "5.24"}]}]}]}, {"type": "SECONDARY", "title": "Behavioral and Psychological Symptoms as Assessed by Neuropsychiatric Inventory (NPI)", "description": "Neuropsychiatric Inventory (NPI) total score ranges from 0-144, with a higher score indicating greater symptoms. The change in total score between the baseline (day 1) and the end of intervention (day 5) is reported.", "populationDescription": "Comparison of NPI score changes between two groups at 5 days from baseline", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "baseline (day 1), end of intervention (day 5)", "groups": [{"id": "OG000", "title": "Active tDCS", "description": "2mA current is applied for 20 minutes."}, {"id": "OG001", "title": "Sham tDCS", "description": "2mA current is applied for 30 seconds."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "20"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-2.9", "spread": "15.08"}, {"groupId": "OG001", "value": "-2.30", "spread": "11.59"}]}]}]}, {"type": "SECONDARY", "title": "Change in Pain Related Cortical Response Using a Continuous Wave, Multichannel Functional Near-infrared Spectroscopy (fNIRS) Imaging System", "description": "Pain-related cortical response will be measured during thermal pain stimulation using a continuous-wave, multichannel fNIRS imaging system (LIGHTNIRS, Shimadzu, Kyoto, Japan) composed of 8 source and 8 detector channels.\n\nfNIRS signals between each source-to-detector pair are analyzed using a general linear model, Y = X\\*Beta + E , to test for statistical differences between the baseline (day 1) and the end of intervention (day 5).\n\nY is the measured fNIRS signal, X is an array encoding the expected/hypothetical response, E is an error term, and Beta is interpreted as the strength/amplitude of the functional activation.\n\nGreater absolute Beta values denote that the change in cortical response between two sessions is greater.\n\nThe calculated Beta values are expressed in arbitrary units.", "populationDescription": "Comparison of Beta value changes between two groups at 5 days from baseline.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Beta value", "timeFrame": "baseline (day 1), end of intervention (day 5)", "groups": [{"id": "OG000", "title": "Active tDCS", "description": "2mA current is applied for 20 minutes."}, {"id": "OG001", "title": "Sham tDCS", "description": "2mA current is applied for 30 seconds."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "20"}]}], "classes": [{"title": "source 1, detector 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "-6.39"}, {"groupId": "OG001", "value": "-5.30"}]}]}, {"title": "source 2, detector 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.31"}, {"groupId": "OG001", "value": "-4.64"}]}]}, {"title": "source 3, detector 3", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.60"}, {"groupId": "OG001", "value": "3.13"}]}]}, {"title": "source 4, detector 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "-8.35"}, {"groupId": "OG001", "value": "-3.46"}]}]}, {"title": "source 5, detector 5", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.03"}, {"groupId": "OG001", "value": "-1.54"}]}]}, {"title": "source 6, detector 6", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.99"}, {"groupId": "OG001", "value": "-3.49"}]}]}, {"title": "source 7, detector 7", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.61"}, {"groupId": "OG001", "value": "-0.97"}]}]}, {"title": "source 8, detector 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.88"}, {"groupId": "OG001", "value": "8.33"}]}]}]}, {"type": "SECONDARY", "title": "Acceptability as Measured by the tDCs Experience Questionnaire", "description": "The tDCS experience questionnaire contains 10 questions based on a scale from 0-10, 0 being strongly disagree and 10 being strongly agree. Higher scores indicating greater acceptability for 7 questions and lower scores indicating greater acceptability for 3 reversed questions. Total score ranges from 0-100 with a most desirable score of a 70.", "populationDescription": "Comparison of total score of tDCS experience questionnaire between two groups at 5 days from baseline.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "end of intervention (day 5)", "groups": [{"id": "OG000", "title": "Active tDCS", "description": "2mA current is applied for 20 minutes."}, {"id": "OG001", "title": "Sham tDCS", "description": "2mA current is applied for 30 seconds."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "20"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "62.05", "spread": "8.76"}, {"groupId": "OG001", "value": "67.95", "spread": "11.06"}]}]}]}, {"type": "SECONDARY", "title": "Patient Satisfaction as Measured by the Client Satisfaction Questionnaire (CSQ)", "description": "Client Satisfaction Questionnaire (CSQ) consists of 8 questions, each is rated between 1-4. The total score ranges from 8-32 with a higher score indicating a higher satisfaction.", "populationDescription": "Comparison of total score of CSQ between two groups at 5 days from baseline.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "end of intervention (day 5)", "groups": [{"id": "OG000", "title": "Active tDCS", "description": "2mA current is applied for 20 minutes."}, {"id": "OG001", "title": "Sham tDCS", "description": "2mA current is applied for 30 seconds."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "20"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "28.75", "spread": "2.92"}, {"groupId": "OG001", "value": "28.55", "spread": "3.14"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "1 week, from the first day of tDCS session to the last day.", "eventGroups": [{"id": "EG000", "title": "Active tDCS", "description": "Active tDCS: tDCS with a constant current intensity of 2 milliampere (mA) will be applied for 20 minutes per session daily for 5 days via the Soterix 1x1 tDCS mini-CT Stimulator device with headgear and 5x7 cm saline-soaked surface sponge electrodes.", "deathsNumAffected": 0, "deathsNumAtRisk": 20, "seriousNumAffected": 0, "seriousNumAtRisk": 20, "otherNumAffected": 0, "otherNumAtRisk": 20}, {"id": "EG001", "title": "Sham tDCS", "description": "Sham tDCS: The electrodes will be placed in the same positions as for active stimulation, but the stimulator will only deliver 2 mA current for 30 seconds.", "deathsNumAffected": 0, "deathsNumAtRisk": 20, "seriousNumAffected": 0, "seriousNumAtRisk": 20, "otherNumAffected": 0, "otherNumAtRisk": 20}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Hyochol Ahn", "organization": "University of Arizona", "email": "hbrian@arizona.edu", "phone": "520-626-1769"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2022-03-01", "uploadDate": "2023-09-18T13:11", "filename": "Prot_001.pdf", "size": 355716}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2022-03-01", "uploadDate": "2023-09-18T16:32", "filename": "SAP_002.pdf", "size": 134907}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "submissionTracking": {"firstMcpInfo": {"postDateStruct": {"date": "2023-09-21", "type": "ACTUAL"}}}}, "conditionBrowseModule": {"meshes": [{"id": "D000000544", "term": "Alzheimer Disease"}, {"id": "D000003704", "term": "Dementia"}], "ancestors": [{"id": "D000001927", "term": "Brain Diseases"}, {"id": "D000002493", "term": "Central Nervous System Diseases"}, {"id": "D000009422", "term": "Nervous System Diseases"}, {"id": "D000024801", "term": "Tauopathies"}, {"id": "D000019636", "term": "Neurodegenerative Diseases"}, {"id": "D000019965", "term": "Neurocognitive Disorders"}, {"id": "D000001523", "term": "Mental Disorders"}], "browseLeaves": [{"id": "M6904", "name": "Dementia", "asFound": "Dementia", "relevance": "HIGH"}, {"id": "M3885", "name": "Alzheimer Disease", "asFound": "Alzheimer's Disease", "relevance": "HIGH"}, {"id": "M13066", "name": "Pain", "relevance": "LOW"}, {"id": "M5204", "name": "Brain Diseases", "relevance": "LOW"}, {"id": "M5742", "name": "Central Nervous System Diseases", "relevance": "LOW"}, {"id": "M23002", "name": "Tauopathies", "relevance": "LOW"}, {"id": "M21558", "name": "Neurodegenerative Diseases", "relevance": "LOW"}, {"id": "M21836", "name": "Neurocognitive Disorders", "relevance": "LOW"}, {"id": "M4815", "name": "Mental Disorders", "relevance": "LOW"}, {"id": "M14473", "name": "Psychotic Disorders", "relevance": "LOW"}, {"id": "T2192", "name": "Familial Alzheimer Disease", "asFound": "Alzheimer's Disease", "relevance": "HIGH"}], "browseBranches": [{"abbrev": "BC10", "name": "Nervous System Diseases"}, {"abbrev": "BXM", "name": "Behaviors and Mental Disorders"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}}, "hasResults": true}